Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Crtomir Podlipnik"'
Publikováno v:
Trends in Pharmaceutical Sciences, Vol 9, Iss 3, Pp 221-236 (2023)
This review describes the Food and Drug Administration (FDA)-approved antiparasitic drugs for sheep and goats in the USA updated to 2021. The emerging drug resistance is posing a significant burden for the treatment of parasitic infections in these s
Externí odkaz:
https://doaj.org/article/f5f78bf8e62340059a8f62809e3c72aa
Autor:
Ljubica Brenjo, Aleksandar Oklješa, Matija Tomšič, Berta Barta Holló, Jovica Nešić, Elvira Tóth, Črtomir Podlipnik
Publikováno v:
Molecules, Vol 29, Iss 14, p 3389 (2024)
The tetrazole moiety remains one of the most interesting scaffolds in the development of new high-energy density materials (HEDMs) because of its desired characteristics, such as high nitrogen content and heat of formation (HOF). The combination of s
Externí odkaz:
https://doaj.org/article/8caa7378ec4f49999d02700e0dfa4595
Autor:
Ali Oubella, Abdelmaoujoud Taia, Said Byadi, Marouane Ait Lahcen, Abdoullah Bimoussa, Mohamed Essaber, Crtomir Podlipnik, Hamid Morjani, My Youssef Ait Itto, Abdeljalil Aatif
Publikováno v:
Journal of biomolecular structuredynamics.
In this research paper, we report the cytotoxic and apoptotic effects of 1,2,3-triazole derivatives in a unique
Autor:
Ali Oubella, Said Byadi, Abdoullah Bimoussa, Mourad Fawzi, Aziz Auhmani, Crtomir Podlipnik, Hamid Morjani, Abdelkhalek Riahi, Anthony Robert, My Youssef A. Itto
Publikováno v:
Archiv der Pharmazie. 355:2200066
In the current study, natural (R)-carvone was utilized as a starting material for the efficient synthesis of two series of isoxazoline derivatives bearing the 1,3,4-thiadiazole moiety. The new compounds were obtained in good yields and were character
Autor:
Alexandrova, Radostina, Alexandrov, Orlin, Beykov, Pencho, Yetik-Anacak, Gunay, Krasilnikova, Jelena, Marinescu, Gabriela, Daniela-Cristina Culita, Crtomir Podlipnik, Chukwuemeka Obinna Ekeh
Nonsteroidal anti-inflammatory drugs (NSAIDs) reversibly inhibit the functioning of cyclooxygenase (COX) – the rate-limiting enzyme in prostaglandin synthesis, and express anti-inflammatory, antipyretic and analgesic effects. NSAIDs are among the m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7df711d4b666619cf0b7b0aeee83092e
Publikováno v:
Acta Chimica Slovenica, Vol 68, Iss 3, Pp 728-735 (2021)
Hydroperoxides are of great importance in the fields of atmospheric and biological chemistry. However, there are several analytical challenges in their analysis: unknown and usually low UV absorption coefficients, high reactivity, thermal instability
Externí odkaz:
https://doaj.org/article/5d19958271e343cf9dc9851f2df6b46d
Publikováno v:
Biotechnology & Biotechnological Equipment, Vol 35, Iss 1, Pp 74-102 (2021)
SARS-CoV-2 is an emerging human beta-coronavirus that caused the COVID-19 (Coronavirus Disease − 19) pandemic, the most significant health and social crisis in the last 100 years. SARS-CoV-2 is not only a respiratory virus; the symptoms of COVID-19
Externí odkaz:
https://doaj.org/article/faaf8b200d4d4c5bbb0e490be0054cad
Autor:
Matic Proj, Steven De Jonghe, Tom Van Loy, Marko Jukič, Anže Meden, Luka Ciber, Črtomir Podlipnik, Uroš Grošelj, Janez Konc, Dominique Schols, Stanislav Gobec
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
We present a state-of-the-art virtual screening workflow aiming at the identification of novel CC chemokine receptor 7 (CCR7) antagonists. Although CCR7 is associated with a variety of human diseases, such as immunological disorders, inflammatory dis
Externí odkaz:
https://doaj.org/article/3605339e4e9943389bdcb765cc43452d
Publikováno v:
Arabian Journal of Chemistry, Vol 13, Iss 1, Pp 1598-1611 (2020)
In this work, four different oxygen functionalized ionic liquids, 1-(3-hydroxypropyl)-3-methylimidazolium chloride,[OHC3mIm][Cl], 1-(3-hydroxypropyl)-3-ethylimidazolium chloride [OHC3eIm][Cl], 1-(2-oxobutyl)-3-methylimidazolium chloride, [C2OC2mIm][C
Externí odkaz:
https://doaj.org/article/23fdf371b67a4fe3b89c2c57081d521c